Man Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $138M | Sell |
3,225,164
-493,567
| -13% | -$26.8M | 0.22% | 98 |
|
|
2026
Q1 | $233M | Sell |
3,718,731
-673,994
| -15% | -$53.9M | 0.42% | 40 |
|
|
2025
Q4 | $419M | Buy |
4,392,725
+548,788
| +14% | +$53.8M | 0.71% | 13 |
|
|
2025
Q3 | $375M | Buy |
3,843,937
+1,706,494
| +80% | +$177M | 0.65% | 13 |
|
|
2025
Q2 | $230M | Buy |
2,137,443
+1,308,711
| +158% | +$132M | 0.44% | 35 |
|
|
2025
Q1 | $83.6M | Buy |
828,732
+557,673
| +206% | +$56.2M | 0.21% | 92 |
|
|
2024
Q4 | $24.2M | Buy |
271,059
+62,662
| +30% | +$5.52M | 0.06% | 361 |
|
|
2024
Q3 | $17.5M | Buy |
208,397
+62,766
| +43% | +$4.95M | 0.05% | 495 |
|
|
2024
Q2 | $11.2M | Sell |
145,631
-51,870
| -26% | -$3.8M | 0.03% | 655 |
|
|
2024
Q1 | $13.5M | Buy |
197,501
+3,029
| +2% | +$195K | 0.03% | 571 |
|
|
2023
Q4 | $11.2M | Buy |
+194,472
| New | +$10.4M | 0.03% | 592 |
|
|
2023
Q3 | – | Sell |
-363,982
| Closed | -$19.1M | – | 400 |
|
|
2023
Q2 | $19.7M | Buy |
+363,982
| New | +$19M | 0.06% | 390 |
|
|
2023
Q1 | – | Sell |
-144,297
| Closed | -$6.8M | – | 979 |
|
|
2022
Q4 | $6.68M | Buy |
+144,297
| New | +$6.25M | 0.02% | 724 |
|
|
2022
Q2 | – | Sell |
-123,666
| Closed | -$5.03M | – | 1462 |
|
|
2022
Q1 | $5.48M | Sell |
123,666
-381,056
| -75% | -$16.5M | 0.02% | 854 |
|
|
2021
Q4 | $21.4M | Sell |
504,722
-661,696
| -57% | -$27.8M | 0.07% | 343 |
|
|
2021
Q3 | $50.6M | Sell |
1,166,418
-236,882
| -17% | -$10.5M | 0.18% | 124 |
|
|
2021
Q2 | $60M | Buy |
1,403,300
+1,214,482
| +643% | +$51.1M | 0.21% | 98 |
|
|
2021
Q1 | $7.3M | Sell |
188,818
-453,319
| -71% | -$17.2M | 0.03% | 541 |
|
|
2020
Q4 | $23.1M | Buy |
642,137
+302,778
| +89% | +$10.9M | 0.1% | 196 |
|
|
2020
Q3 | $13M | Buy |
339,359
+293,587
| +641% | +$11.3M | 0.05% | 391 |
|
|
2020
Q2 | $1.61M | Sell |
45,772
-48,042
| -51% | -$1.73M | 0.01% | 1134 |
|
|
2020
Q1 | $3.06M | Sell |
93,814
-133,852
| -59% | -$5.23M | 0.02% | 698 |
|
|
2019
Q4 | $10.3M | Buy |
227,666
+140,182
| +160% | +$5.87M | 0.03% | 683 |
|
|
2019
Q3 | $3.56M | Sell |
87,484
-53,637
| -38% | -$2.27M | 0.01% | 1029 |
|
|
2019
Q2 | $6.07M | Sell |
141,121
-162,165
| -53% | -$6.24M | 0.02% | 866 |
|
|
2019
Q1 | $11.6M | Buy |
303,286
+18,416
| +6% | +$703K | 0.04% | 509 |
|
|
2018
Q4 | $10.1M | Sell |
284,870
-490,583
| -63% | -$17.8M | 0.04% | 449 |
|
|
2018
Q3 | $29.9M | Sell |
775,453
-483,565
| -38% | -$16.9M | 0.11% | 199 |
|
|
2018
Q2 | $41.2M | Buy |
1,259,018
+895,617
| +246% | +$27M | 0.17% | 116 |
|
|
2018
Q1 | $9.93M | Buy |
+363,401
| New | +$9.88M | 0.05% | 492 |
|
Other funds holding BSX
Man Group's BSX Position: Q2 2026 in Review
Man Group reduced its Boston Scientific (BSX) stake by 13% in Q2 2026, selling an estimated $26.8M and leaving 3,225,164 shares worth $138M. The position accounts for 0.22% of the portfolio, ranked #98.
Man Group first reported a position in BSX in Q1 2018 and has held it in 30 quarters since. The position peaked at $419M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Man Group held 3,225,164 shares of Boston Scientific worth $138M as of Q2 2026.
- Man Group sold 493,567 Boston Scientific shares in Q2 2026, an estimated $26.8M.
- Boston Scientific made up 0.22% of Man Group's portfolio in Q2 2026, its #98 holding.
- Man Group first reported a position in Boston Scientific in Q1 2018 and has held it in 30 quarters since.
- Man Group's Boston Scientific position peaked at $419M in Q4 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.